USPTO serial 74086447
TANTA
Reviewed by CopyMark Law Group
Reg. 1981828Status 710
- Filing date
- Status date
- Registration date
- Jun 25, 1996
- Examiner
- MULLEN, MARK
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with TANTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
WHITBY, ONTARIO, L1N 6A6, CA
WHITBY, ONTARIO, L1N 6A6, CA
WHITBY, ONTARIO, L1N 6A6, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas J. Hoffmann
THOMAS J HOFFMANN HOFFMANNS, LTD53 W JACKSON BLVDSTE 1350CHICAGO, IL 60604-3790Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | personal care products, namely cosmetic creams, essential oils for personal use, deodorant soaps, body soaps, body lotions and tonics, cosmetic preparations for baths, namely bath salts, bath soaps and bath fragrances, hair lotions, namely for setting and styling, hair rinses, hydrogen peroxide for cosmetic purposes, petroleum gels for cosmetic purposes and mouthwashes not for medical purposes | SECTION 8 - CANCELLED | — |
| 005 | pharmaceutical preparations, namely antacids, gastrointestinal sedatives, laxatives, purgatives and lubricants, drugs acting on the colon and rectum, anti-diarrhoeals, enzymes, digestives and hepato-biliary drugs for the care, prevention, diagnosis and treatment of the alimentary system; anginal drugs and coronary vasodilators, peripheral vasodilators, anti-hypertensives, vasoconstrictors and migrain treatments, anti-coagulants and antithrombotics, haemostatics for the care and treatment of the cardiovascular system; analgesics and anti-pyretics, hyponotics, sedatives and tranquilisers, anti-depressants, anti-emetics and anti-nauseants, anti-convulsants, rigidity and tremor controllers, C.N.S. stimulants and metabolic activators for treatment of the central nervous system; non-steroid, anti-inflammatory drugs, muscle relaxants, rubefacients, neuromuscular drugs for the treatment of musculo-skeletal disorders; hormonal drugs, namely Gonodal hormones, oral contraceptives, corticosteroids, tropic hormones, hyper and hypoglycaemics, thyroid and anti-thyroid drugs; diuretics and anti-diuretics, urinary anti-infectives and anti-spasmodics, local and systemic drugs for vaginal and urethral conditions, drugs acting on the uterus, and spermicidal contraceptives for treatment of the genito-urinary system; antibiotics, sulphonamides and other antibacterials, anti-tuberculous drugs, antileprotics, antifungals, anti-amoebics, anti-malarials, anthelmintics and other anti-infestive drugs, antivirals, sera, vaccines and immunizers for treatment of infections and infestations; nutritional drink mix for use as a meal replacement, appetite stimulants, iron supplements, erythropoeitic drugs, minerals and nutritional additives, vitamins, anti-obestity drugs, anabolic drugs for the treatment and care of nutrition; respiratory stimulants, bronochospasm relaxants, expectorants, cough suppressants, mucolytics and decongestants for treatment of the respiratory system; local reactants on the nose, oropharyngeal and aural preparations for treatment of the ear, nose and oropharynx; anti-infective preparations, anti-inflammatory and anti-allergic preparations (steroid and non-steroid), glaucoma, mydriatics and cyclopiegics for treatment of the eye; anti-allergic drugs and desensitising preparations for treatment of allergic disorders; Keratolytics and medicated cleansing preparations for the skin, topical non-steroid anti-prurtic and anti-inflammatory preparations, topical anti-fungal and anti-infestive preparations, topical anti-infective preparations, topical steroid preparations all for the treatment and care of the skin; for treatment and care of the skin; carcino-chemotherapeutic drugs, immunosuppresants for care and treatment of metabolism; anaesthetics for pre-medication, surgical anti-bacterial preparations, mucolytic, proteolytic enzymes, plasma expanders for surgical use; surgical bandages; bandages for skin wounds; cleaning solutions for contact lenses; and disposable medical products, namely surgical dressings, wound dressings and burn dressings | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TANTA PHARMACEUTICALS, LTD.
- Other trademarks owned by TANTA PHARMACEUTICALS, LTD.
- Other trademarks owned by TANTA PHARMACEUTICALS, LTD.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named TANTA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 29, 2003 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 25, 1996 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 2, 1996 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 1, 1996 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 3, 1996 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 1995 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 1995 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 6, 1995 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 1995 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jan 9, 1995 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 1994 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 1994 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jun 27, 1994 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 1994 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 1993 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 4, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 1993 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 15, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 1992 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 23, 1992 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Aug 27, 1992 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jun 8, 1992 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 1992 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 5, 1992 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 1991 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 12, 1991 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 1991 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 1990 | DOCK | ASSIGNED TO EXAMINER | — |